Rua Bioscience

[Gipseboy]

Reasons for trading halt, including impact of event on fair orderly or transparent markets: Rua has signed an Agreement with an international counterparty in the UK. Rua is mindful of its continuous disclosure obligations and is not in a position to release further details about the agreement until a joint announcement is made with the international counterparty, which is also a publicly listed company. Therefore, we consider it prudent to seek a trading halt to prevent a risk of trading in an uninformed market.

Am I being over optimistic here or is this finally some good news for Rua, (Been holding for several years entering at 45c per share) Fingers crossed

[Auto Rower]

Reasons for trading halt, including impact of event on fair orderly or transparent markets: Rua has signed an Agreement with an international counterparty in the UK. Rua is mindful of its continuous disclosure obligations and is not in a position to release further details about the agreement until a joint announcement is made with the international counterparty, which is also a publicly listed company. Therefore, we consider it prudent to seek a trading halt to prevent a risk of trading in an uninformed market.

Am I being over optimistic here or is this finally some good news for Rua, (Been holding for several years entering at 45c per share) Fingers crossed

If the greens get in power with  te pati Māori through labour & legalize cannabis or hold another vote  then you will have a good chance .
otherwise its all gone up in smoke 

[Hectorplains]

Rua is growing for the medical, export market.  The configuration of the NZ Government is largely irrelevant to them. 

To date they've been funding their operational cash burn (which sits at a net cash outflow from operating activities of NZ$2.5 million to NZ$3.5 million per year) by capital raises. 

This UK distribution agreement is projected to bring in $10+ million over two years. If they can maintain their current revenue in Germany, Australia, and New Zealand on top of this, their total annual revenue could push closer to $7M–$8M+.

At that higher threshold, Rua could pivot from a struggling, cash-burning startup towards being a self-sustaining, profitable export business.

For now, they are still reliant on the upcoming capital raises mentioned in their Annual Report to bridge the gap until, hopefully, that UK cash starts coming in. 

A caveat on that $10 million figure... it is a projection, and there is no guaranteed immediate "cure" for Rua's severe cash burn (they currently have less than a year of cash runway left.)  Rua's previous projections have all proved to be unduly optimistic.  A deal with the mystery partner taking an the equity stake would have been more reassuring.